ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs MXN
16.6998
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,623.06
0.13%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Bioenvision (MM) (BIVN)

  7. Bioenvision (MM) (BIVN) Noticias

BIVN

Bioenvision (BIVN)

Bioenvision (MM)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BIVN
FechaHoraFuenteTítuloSímboloCompañía
11/04/201707:30GlobeNewswire Inc.MonoSol Rx Appoints James S. Scibetta to Board of DirectorsNASDAQ:BIVNBioenvision (MM)
23/10/200716:40PR Newswire (US)HealthShares(TM) Announces Change to the HealthShares(TM) Emerging Cancer IndexNASDAQ:BIVNBioenvision (MM)
22/10/200715:50PR Newswire (US)Bioenvision Shareholders Approve Acquisition by Genzyme CorporationNASDAQ:BIVNBioenvision (MM)
10/10/200713:57PR Newswire (US)Delaware Court Approves Bioenvision, Genzyme Joint PetitionNASDAQ:BIVNBioenvision (MM)
05/10/200716:00Edgar (US Regulatory)Bioenvision Inc - Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
01/10/200708:17Edgar (US Regulatory)Bioenvision Inc (Other) (SC 13D/A)NASDAQ:BIVNBioenvision (MM)
27/09/200707:45PR Newswire (US)Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding ShareNASDAQ:BIVNBioenvision (MM)
27/09/200707:31Edgar (US Regulatory)Bioenvision Inc (Other) (DFAN14A)NASDAQ:BIVNBioenvision (MM)
20/09/200713:15Edgar (US Regulatory)Bioenvision Inc (Other) (DEFA14A)NASDAQ:BIVNBioenvision (MM)
19/09/200716:11Edgar (US Regulatory)Bioenvision Inc (Other)NASDAQ:BIVNBioenvision (MM)
06/09/200708:49PR Newswire (US)Elliott 'Extremely Dissatisfied' With Genzyme Bid for Bioenvision; Believes Offer Significantly Undervalues CompanyNASDAQ:BIVNBioenvision (MM)
16/08/200707:00Business WireBioenvision Provides Evoltra(R) (clofarabine) Regulatory UpdateNASDAQ:BIVNBioenvision (MM)
27/07/200717:24PR Newswire (US)Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
26/07/200715:30Business WireBioenvision, Inc. Says Securities Class Action Litigation Without MeritNASDAQ:BIVNBioenvision (MM)
16/07/200708:00Business WireDr. Andrew N. Schiff and Steven A. Elms Resign from Bioenvision Board of DirectorsNASDAQ:BIVNBioenvision (MM)
10/07/200713:44PR Newswire (US)/C O R R E C T I O N -- Genzyme Corporation/NASDAQ:BIVN
10/07/200708:27PR Newswire (US)Genzyme Completes Tender Offer to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
02/07/200709:45PR Newswire (US)Genzyme Extends Tender Offer to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
27/06/200712:30PR Newswire (US)Genzyme Corporation Moves Closer to Acquiring Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
29/05/200709:09PR Newswire (US)Genzyme Corporation to Acquire Bioenvision, Inc.NASDAQ:BIVNBioenvision (MM)
08/05/200706:00Business WireBioenvision Reports Third Quarter 2007 Financial ResultsNASDAQ:BIVNBioenvision (MM)
07/05/200706:02Business WireBioenvision Receives $7.4 Million in Warrant Exercises by Perseus-Soros Biopharmaceutical Fund & SCO CapitalNASDAQ:BIVNBioenvision (MM)
03/05/200706:02Business WireBioenvision to Present at 2007 UBS Global Generic and Specialty Pharmaceuticals ConferenceNASDAQ:BIVNBioenvision (MM)
01/05/200706:02Business WireBioenvision to Hold Fiscal 2007 Third Quarter Financial Results Conference Call on Tuesday, May 8, 2007NASDAQ:BIVNBioenvision (MM)
09/04/200706:02Business WireBioenvision to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals ConferenceNASDAQ:BIVNBioenvision (MM)
02/04/200705:59Business WireBioenvision Announces Registered Direct Offering of $30 Million in Common StockNASDAQ:BIVNBioenvision (MM)
01/02/200706:00Business WireBioenvision Licenses Its Proprietary Antimicrobial Technology to Foster CorporationNASDAQ:BIVNBioenvision (MM)
31/01/200711:12Business WireBioenvision to Hold Fiscal 2007 Second Quarter Financial Results Conference Call on Thursday, February 8, 2007NASDAQ:BIVNBioenvision (MM)
08/01/200706:00Business WireBioenvision to Present at 25th Annual JPMorgan Healthcare ConferenceNASDAQ:BIVNBioenvision (MM)
11/12/200613:59Business WireNew Evoltra(R) Data Shows Impressive Response and Survival RatesNASDAQ:BIVNBioenvision (MM)
 Showing the most relevant articles for your search:NASDAQ:BIVN

Su Consulta Reciente

AMEX
TYNS
Direxion Daily 7 10 Year...
LSE
AS82
Barclays 29
LSE
SA94
Bank Nova.24
USOTC
CSSEZ
Chicken Soup for the Sou... (PK)
TSX
KEY
Keyera
GATE
PERAUSDT
Pera Finance
EU
9289T
9289T
GATE
SEIUSDT
Sei
LSE
BO82
Barclays 26
GATE
IDUSDT
Space ID
TSXV
SSV
Southern Silver Explorat...
AMEX
DEUS
Xtrackers Russell US Mul...
GATE
SCNSOLETH
Socean Staked Sol
BIT
UB0P2H
UniCredit Bank
BIT
F17444
Vontobel Financial Produ...
NASDAQ
SRCH
US Search
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados